Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Autosomal Dominant Juvenile Parkinson Disease

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akita, H1
Honda, Y1
Ogata, M1
Noda, K1
Saji, M1
Marin, C1
Jimenez, A1
Bonastre, M1
Chase, TN1
Tolosa, E1

Other Studies

2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats.
    Brain research, 2010, Jan-08, Volume: 1306

    Topics: Animals; Deep Brain Stimulation; Dizocilpine Maleate; Dyskinesias; Excitatory Amino Acid Antagonists

2010
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.
    Synapse (New York, N.Y.), 2000, Jun-15, Volume: 36, Issue:4

    Topics: Animals; Antiparkinson Agents; Dextromethorphan; Excitatory Amino Acid Antagonists; Levodopa; Male;

2000